Fundz

Who to call at Gilead Sciences, and when

Fundz watches for the moments Gilead Sciences starts buying, and tells you who to reach.

  • An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gilead Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Gilead Sciences Expands Collaboration with WHO to Combat Visceral Leishmaniasis.

May 21, 2026

Contract Type

partnership

Foster CityBiotechnologyHealth CareTherapeuticsBiopharma

Description

Gilead Sciences has renewed a five-year partnership with the World Health Organization to eliminate visceral leishmaniasis. The agreement includes providing over 400,000 vials of AmBisome and contributing $9.2 million in financial support through 2030, focusing on East Africa and several other countries.

Company Information

Company

Gilead Sciences

Location

333 Lakeside Dr

Foster City, California, United States

About

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, cancer and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Related People

Daniel
Senior decision-maker at this company
••••••••@••••••••

See Daniel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gilead Sciences's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Gilead Sciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.